Decomit Plus Inhaler (100 mcg + 6 mcg)/puff is a combination inhalation therapy containing Beclomethasone Dipropionate and Formoterol Fumarate, designed for the long-term management of asthma and other chronic obstructive airway diseases. This dual-action formulation provides both anti-inflammatory and bronchodilator effects, helping patients achieve better symptom control and improved lung function.

Beclomethasone Dipropionate is an inhaled corticosteroid that reduces inflammation, swelling, and mucus production in the airways. Formoterol Fumarate is a long-acting beta-2 agonist (LABA) that relaxes bronchial smooth muscles, leading to sustained bronchodilation and easier breathing. Together, these agents work synergistically to control airway inflammation while maintaining prolonged airway openness.

রেজিস্টার্ড চিকিৎসকের পরামর্শ অনুযায়ী ঔষধ সেবন করুন

Therapeutic Indications

Decomit Plus Inhaler is indicated for:

• Maintenance treatment of bronchial asthma

• Long-term management of moderate to severe persistent asthma

• Patients not adequately controlled with inhaled corticosteroids alone

• Improvement of airflow limitation and prevention of asthma exacerbations

Dosage and Administration

The dosage of Decomit Plus Inhaler should be individualized based on disease severity and patient response. It is usually administered twice daily, or as directed by a healthcare professional. The inhaler should be used regularly to achieve maximum benefit and not as a rescue medication for sudden asthma attacks.

Patients should be instructed on correct inhalation technique to ensure optimal drug delivery to the lungs. Rinsing the mouth with water after inhalation and spitting it out is recommended to reduce the risk of oral fungal infections.

Key Benefits

• Dual-action therapy for comprehensive asthma control

• Reduces airway inflammation and prevents symptom worsening

• Provides long-lasting bronchodilation

• Improves lung function and breathing comfort

• Convenient combination inhaler enhances treatment adherence

Precautions and Warnings

Decomit Plus Inhaler should not be used for immediate relief of acute bronchospasm. A fast-acting bronchodilator should be available for emergency use. Caution is advised in patients with cardiovascular disorders, hyperthyroidism, or diabetes due to the presence of a long-acting beta-agonist.

Long-term use should be monitored by a healthcare professional. The inhaler should not be discontinued abruptly without medical advice.

রেজিস্টার্ড চিকিৎসকের পরামর্শ অনুযায়ী ঔষধ সেবন করুন

Possible Side Effects

Common side effects may include throat irritation, hoarseness, cough, headache, palpitations, and mild tremor. Oral candidiasis may occur due to the corticosteroid component and can be minimized by mouth rinsing after use. Rare systemic corticosteroid effects may occur with prolonged use at high doses.

Storage Conditions

Store Decomit Plus Inhaler (100 mcg + 6 mcg)/puff at room temperature, away from direct heat and sunlight. Do not puncture or expose the canister to high temperatures. Keep out of reach of children.

Decomit Plus Inhaler (100 mcg + 6 mcg)/puff offers effective, long-term control of asthma symptoms through a balanced combination of anti-inflammatory and bronchodilator actions, helping patients maintain better respiratory health and quality of life.